Cargando…
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
Studies on siRNA delivery have seen intense growth in the past decades since siRNA has emerged as a new class of gene therapeutics for the treatment of various diseases. siRNA bioconjugate, as one of the major delivery strategies, offers the potential to enhance and broaden pharmacological propertie...
Autor principal: | Tai, Wanyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631009/ https://www.ncbi.nlm.nih.gov/pubmed/31200490 http://dx.doi.org/10.3390/molecules24122211 |
Ejemplares similares
-
Current Development of siRNA Bioconjugates: From Research to the Clinic
por: Chernikov, Ivan V., et al.
Publicado: (2019) -
A ribonucleoprotein octamer for targeted siRNA delivery
por: Tai, Wanyi, et al.
Publicado: (2018) -
Design of siRNA
Bioconjugates for Efficient Control
of Cancer-Associated Membrane Receptors
por: Lee, Jong Won, et al.
Publicado: (2023) -
Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013) -
Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)